Analysts’ Updated EPS Estimates for September 13th (ADBE, APLS, BMRN, BNTX, COTY, CTLP, DOOO, DV, EVTL, EXAS)

Analysts’ updated eps estimates for Friday, September 13th:

Adobe (NASDAQ:ADBE) had its target price trimmed by UBS Group AG from $560.00 to $550.00. The firm currently has a neutral rating on the stock.

Apellis Pharmaceuticals (NASDAQ:APLS) had its price target trimmed by JPMorgan Chase & Co. from $64.00 to $57.00. The firm currently has an overweight rating on the stock.

BioMarin Pharmaceutical (NASDAQ:BMRN) had its hold rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a $93.00 target price on the stock.

BioNTech (NASDAQ:BNTX) had its price target boosted by Jefferies Financial Group Inc. from $90.00 to $96.00. The firm currently has a hold rating on the stock.

Coty (NYSE:COTY) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a $14.00 price target on the stock.

Cantaloupe (NASDAQ:CTLP) had its outperform rating reaffirmed by analysts at Barrington Research. Barrington Research currently has a $10.00 price target on the stock.

BRP (NASDAQ:DOOO) had its price target cut by UBS Group AG from $66.00 to $65.00. UBS Group AG currently has a neutral rating on the stock.

DoubleVerify (NYSE:DV) had its buy rating reiterated by analysts at The Goldman Sachs Group, Inc.. The firm currently has a $28.00 price target on the stock.

Vertical Aerospace (NYSE:EVTL) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $1.50 target price on the stock.

Exact Sciences (NASDAQ:EXAS) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $75.00 price target on the stock.

Hess (NYSE:HES) had its price target reduced by Piper Sandler from $173.00 to $167.00.

Inter Parfums (NASDAQ:IPAR) had its buy rating reaffirmed by analysts at DA Davidson. DA Davidson currently has a $163.00 price target on the stock.

Lineage (NASDAQ:LINE) had its target price lowered by The Goldman Sachs Group, Inc. from $105.00 to $104.00. The firm currently has a buy rating on the stock.

Lovesac (NASDAQ:LOVE) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $36.00 target price on the stock.

Seres Therapeutics (NASDAQ:MCRB) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $10.00 price target on the stock.

Middleby (NASDAQ:MIDD) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $164.00 price target on the stock.

ModivCare (NASDAQ:MODV) had its target price reduced by Jefferies Financial Group Inc. from $25.00 to $14.00. They currently have a hold rating on the stock.

60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its neutral rating reissued by analysts at HC Wainwright.

Titan Machinery (NASDAQ:TITN) had its market perform rating reaffirmed by analysts at Northland Securities. They currently have a $25.00 target price on the stock.

Tesla (NASDAQ:TSLA) had its target price raised by Guggenheim from $134.00 to $153.00. Guggenheim currently has a sell rating on the stock.

Tesla (NASDAQ:TSLA) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $254.00 price target on the stock.

Travere Therapeutics (NASDAQ:TVTX) had its price target raised by JPMorgan Chase & Co. from $20.00 to $23.00. The firm currently has an overweight rating on the stock.

Frontier Group (NASDAQ:ULCC) had its target price cut by Bank of America Co. from $5.50 to $5.00. The firm currently has a neutral rating on the stock.

Workday (NASDAQ:WDAY) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a $300.00 price target on the stock.